default author photo

Hidetaka Kawabata

Toranomon Hospital - Department of Breast and Endocrine Surgery

Tokyo, 105-8470

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

152

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Phase 2 Study of Nivolumab Plus Bevacizumab Plus Paclitaxel in Patients with HER2-Negative Metastatic Breast Cancer

Number of pages: 34 Posted: 04 May 2021
Toranomon Hospital - Department of Medical Oncology, Showa University - Advanced Cancer Translational Research Institute, National Cancer Center Hospital East - Department of Breast and Medical Oncology, Kindai University - Department of Medical Oncology, National Hospital Organization Hokkaido Cancer Center - Department of Breast Surgery, Toranomon Hospital - Department of Medical Oncology, Toranomon Hospital - Department of Breast and Endocrine Surgery, Nagoya University - Graduate School of Medicine, Gifu University - Department of Surgical Oncology, Kobe University - Medical Oncology/Hematology, Hyogo Cancer Center - Department of Medical Oncology, Hiroshima University Hospital - Center for Integrated Medical Research, National Cancer Center Hospital - Department of Experimental Therapeutics and Toranomon Hospital - Department of Medical Oncology
Downloads 106 (659,487)

Abstract:

Loading...

2.

Safety and Efficacy of Nivolumab Plus Bevacizumab, Paclitaxel for HER2-Negative Metastatic Breast Cancer: Primary Result and Biomarker Data of a Phase 2 Trial

Number of pages: 51 Posted: 03 Mar 2022
Toranomon Hospital - Department of Medical Oncology, affiliation not provided to SSRN, National Cancer Center Hospital East - Department of Breast and Medical Oncology, Kindai University - Department of Medical Oncology, Hokkaido University - Hokkaido University Hospital, Toranomon Hospital - Department of Medical Oncology, Toranomon Hospital - Department of Breast and Endocrine Surgery, Nagoya University - Graduate School of Medicine, Gifu University - Department of Surgical Oncology, Kobe University - Medical Oncology/Hematology, affiliation not provided to SSRN, Hiroshima University Hospital - Center for Integrated Medical Research, National Cancer Center Hospital - Department of Experimental Therapeutics and Toranomon Hospital - Department of Medical Oncology
Downloads 46 (1,108,890)

Abstract:

Loading...

Nivolumab, Bevacizumab, immunotherapy, VEGF, Metastatic breast cancer